Intelligent Bio Solutions Inc (INBS)

$1.53

-0.08

(-4.97%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $1.52
    $1.62
    $1.53
    downward going graph

    0.63%

    Downside

    Day's Volatility :6.15%

    Upside

    5.56%

    downward going graph
  • $1.52
    $31.20
    $1.53
    downward going graph

    0.65%

    Downside

    52 Weeks Volatility :95.13%

    Upside

    95.1%

    downward going graph

Returns

PeriodIntelligent Bio Solutions IncIndex (Russel 2000)
3 Months
-42.48%
0.0%
6 Months
-58.33%
0.0%
1 Year
-94.43%
0.0%
3 Years
-98.65%
-19.6%

Highlights

Market Capitalization
5.0M
Book Value
$3.82
Earnings Per Share (EPS)
-29.56
Wall Street Target Price
12.0
Profit Margin
0.0%
Operating Margin TTM
-358.55%
Return On Assets TTM
-45.62%
Return On Equity TTM
-118.96%
Revenue TTM
2.8M
Revenue Per Share TTM
3.29
Quarterly Revenue Growth YOY
80.2%
Gross Profit TTM
326.7K
EBITDA
-9.3M
Diluted Eps TTM
-29.56
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-3.67
EPS Estimate Next Year
-1.25
EPS Estimate Current Quarter
-0.87
EPS Estimate Next Quarter
-0.51

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Intelligent Bio Solutions Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 684.31%

Current $1.53
Target $12.00

Technicals Summary

Sell

Neutral

Buy

Intelligent Bio Solutions Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Intelligent Bio Solutions Inc
Intelligent Bio Solutions Inc
-18.62%
-58.33%
-94.43%
-98.65%
-98.65%
Stryker Corporation
Stryker Corporation
0.55%
8.84%
17.27%
31.59%
63.53%
Boston Scientific Corp.
Boston Scientific Corp.
1.11%
27.69%
48.67%
78.09%
82.49%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
-4.07%
15.09%
-5.36%
-19.2%
33.76%
Abbott Laboratories
Abbott Laboratories
-3.11%
-10.65%
-10.98%
-13.72%
15.85%
Medtronic Plc
Medtronic Plc
-1.92%
-8.08%
-10.46%
-37.47%
-21.49%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Intelligent Bio Solutions Inc
Intelligent Bio Solutions Inc
0.04
NA
NA
-3.67
-1.19
-0.46
NA
3.82
Stryker Corporation
Stryker Corporation
37.9
37.9
2.92
11.95
0.19
0.07
0.01
50.33
Boston Scientific Corp.
Boston Scientific Corp.
63.49
63.49
1.8
2.33
0.09
0.05
NA
13.56
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
36.97
36.97
5.19
2.76
0.21
0.12
NA
11.82
Abbott Laboratories
Abbott Laboratories
31.57
31.57
5.99
4.63
0.15
0.06
0.02
22.31
Medtronic Plc
Medtronic Plc
29.42
29.42
1.52
5.2
0.07
0.04
0.03
38.29
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Intelligent Bio Solutions Inc
Intelligent Bio Solutions Inc
Buy
$5.0M
-98.65%
0.04
0.0%
Stryker Corporation
Stryker Corporation
Buy
$126.2B
63.53%
37.9
16.03%
Boston Scientific Corp.
Boston Scientific Corp.
Buy
$111.1B
82.49%
63.49
12.05%
Edwards Lifesciences Corp.
Edwards Lifesciences Corp.
Buy
$52.1B
33.76%
36.97
23.01%
Abbott Laboratories
Abbott Laboratories
Buy
$174.1B
15.85%
31.57
13.96%
Medtronic Plc
Medtronic Plc
Buy
$104.1B
-21.49%
29.42
11.36%

Insights on Intelligent Bio Solutions Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 764.06K → 823.8K (in $), with an average increase of 7.3% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -1.96M → -2.97M (in $), with an average decrease of 51.2% per quarter

  • Vs BSX

    In the last 1 year, Boston Scientific Corp. has given 45.9% return, outperforming this stock by 140.4%

Institutional Holdings

  • Alyeska Investment Group, L.P.

    6.62%
  • Hudson Bay Capital Management LP

    3.47%
  • CVI Holdings LLC

    3.47%
  • ADAR1 Capital Management LLC

    3.47%
  • Vanguard Group Inc

    0.50%
  • Geode Capital Management, LLC

    0.46%

Company Information

Organization
Intelligent Bio Solutions Inc
Employees
51
CEO
Mr. Harry Simeonidis
Industry
Miscellaneous

FAQs